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doi:10.1016/j.asjsur.2012.04.012Summary Hepatocellular carcinoma (HCC) occurring in pregnancy is very rare. The prognosis
is usually poor because of unclear clinical presentation. A 30-year-old woman who suffered
from HCC during pregnancy underwent hepatectomy twice, and resection for pulmonary
metastasis once. A healthy infant was delivered after the first hepatectomy. Currently, she
remains disease free 55 months after the second hepatectomy and 39 months after pulmonary
metastatectomy. Moreover, she had another healthy infant 37 months after pulmonary metas-
tatectomy. Aggressive resection of recurrent HCC may prolong life, and pregnancy should not
alter the treatment strategy for HCC.
Copyright ª 2012, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Cancer in pregnancy is rare and coexistence of hepatocel-
lular carcinoma (HCC) with pregnancy is extremely rare.1
HCC in pregnancy is usually asymptomatic at the early
stages and is therefore beyond diagnosis and therapy at
presentation. Liver resection remains the main therapeutic
option for HCC, but the recurrence rate is still high.2ent of Surgery, Taichung
ction 3, Chung-Kang Road,
C.-C. Wu).
n Surgical Association. PublishedFor HCC in pregnancy, resection of tumor without
termination of pregnancy has been suggested.3 However,
no long-term survival after recurrence of HCC in pregnancy
has been reported to the best of our knowledge. Herein, we
report a rare case of a woman with HCC during pregnancy
who underwent hepatectomy twice and resection for
pulmonary metastasis once. She had long-term survival and
had a second healthy delivery after treatment of HCC.
2. Case report
A 30-year-old woman presented with her first pregnancy
at 25 weeks gestation. She received routine pregnancyby Elsevier Taiwan LLC. All rights reserved.
Figure 2 Computed tomography showed a hypervascular
mass, 47 mm in size, over segment 7 of the liver (arrow).
Resection of hepatocellular carcinoma in pregnancy 125check-up and abdominal ultrasonography incidentally
revealed a tumor mass over the right lobe of the liver. She
was seronegative for both hepatitis B and C viruses. The
maternal serum a-fetoprotein was 305 ng/mL (normal
range: < 12 ng/mL). Magnetic resonance imaging showed
a 42-mm hepatic mass with an irregular margin at the
inferior part of segment (S)6 (Fig. 1). We performed sub-
segmentectomy of S6 and cholecystectomy at 26 weeks
gestation. No cirrhosis was found during the operation. The
pathology reported an HCC, which was poorly differenti-
ated, with a free resection margin. The patient recovered
uneventfully and was discharged home on postoperative
day 8.
Abdominal ultrasonography at 39 weeks gestation
showed a hypoechoic tumor, 33 mm in size over the right
lobe of the liver. A male infant weighing 3.396 kg was
delivered by Cesarean section due to dysfunctional labor,
which was performed at gestational week 41. One week
later, computed tomography showed a lobulated hyper-
vascular mass about 47 mm in S7 of the liver (Fig. 2). Wedge
resection of S7 was carried out one month after delivery
with an uneventful recovery.
During the following period, the serum a-fetoprotein
level was within the normal range. However, a well-defined
nodule, 7 mm in size over the lingular segment of the left
lung was noted by chest computed tomography 14 months
after the previous operation (Fig. 3). Wedge resection of
the anterior segment of the left lung was performed. The
pathology reported the nodule as metastatic HCC.
The patient was pregnant again 29 months after lung
resection and a healthy male infant was delivered at
gestational week 36. At present, the patient remains free
of HCC 55 months after the second hepatectomy and 39
months after pulmonary metastatectomy.Figure 1 Magnetic resonance imaging showed a 42-mm
hepatic mass in the inferior part of segment 6, with a slightly
high signal on no-fat-saturated T2-weighted imaging (arrow).3. Discussion
HCC during pregnancy is a rare event, and only 48 cases
have been reported in the literature since 1957.4 The risk
factors are African descent, cirrhosis, positivity for hepa-
titis B surface antigen, multiparity, and a family history of
HCC with long-term usage of oral contraceptives.5,6 It has
been reported that the 3-year survival rate and the median
survival of HCC in pregnancy are only 13.6% and 18 months,
respectively.4 As a result of poor prognosis of HCC in
pregnancy, past reports have emphasized the need for
termination of pregnancy as part of treatment.1,7
The treatment strategy for HCC includes surgery,
transarterial chemoembolization, systemic chemotherapy,Figure 3 Computed tomography showed a well-defined
nodule, 7 mm in size, over the upper lobe of the left lung
(arrow).
126 C.-C. Hung et al.radiofrequency ablation, and ethanol injection. Liver
resection has been a main treatment for HCC, although the
recurrence rate is high.2,4 Currently, repeat hepatectomy
seems to be a better choice for recurrent HCC.8 However,
to the best of our knowledge, no long-term survival of
recurrent HCC in pregnancy has been reported in the
literature.
The most common site of extrahepatic recurrence of
HCC is the lung. HCC during pregnancy with distant
metastasis had been reported in 8/40 patients and the
prognosis was poor.1,4 However, pulmonary resection for
metastatic HCC, as long as there is no concurrent cancer or
other recurrence, could provide long-term survival.9 We
suggest performing pulmonary metastatectomy to achieve
long-term survival.
If recurrent HCC is noted in the third trimester of
pregnancy, resection may be favored after delivery
because the complications of anesthesia are potentiated
due to pregnancy-related changes in physiology.10
In our case, the patient did not have any of the afore-
mentioned risk factors. She was adamant about continuing
the pregnancy and we performed curative resection at 26
weeks gestation. Although liver recurrence and pulmonary
metastasis were found, respective R0 resections were
done. Thirty-nine months after lung resection, there was no
evidence of further recurrent tumor. Moreover, the patient
became pregnant again 29 months after lung resection. The
infants have done well. When physicians keep the safety of
the fetus in mind and work in cooperation with gynecolo-
gists, we believe that pregnancy should not alter the
treatment strategy for HCC.
Herein, we recommend that treatment for HCC during
pregnancy should be similar to that for nonpregnant
women. Complete excision of tumor without termination ofpregnancy, even if there is liver recurrence and pulmonary
metastasis, provides the greatest chance of survival for
women with HCC during pregnancy. Moreover, there is also
no evidence of contraindication for another pregnancy.
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